Price
Target price
€0.33
€0.33
8.440%
0.026
8.440%
€1.60
08.05.24 / Stuttgart Stock Exchange
WKN: A3DHEU / Symbol: NVIV / Name: InVivo Therapeutics Holdings / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
InVivo Therapeutics Holdings Stock
InVivo Therapeutics Holdings dominated the market today, gaining €0.026 (8.440%).
With 17 Sell predictions and only 1 Buy predictions the community sentiment for InVivo Therapeutics Holdings is rather negative.
However, we have a potential of 199.4% for InVivo Therapeutics Holdings as the target price of 1 € is above the current price of 0.33 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for InVivo Therapeutics Holdings stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of InVivo Therapeutics Holdings in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of InVivo Therapeutics Holdings vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
InVivo Therapeutics Holdings | 8.440% | 7.742% | 79.570% | -74.109% | -51.453% | -99.929% | -99.960% |
Star Equity Holdings Inc. | 2.370% | 2.976% | 0.581% | 16.107% | -7.979% | -61.384% | -85.679% |
Atossa Genetics Inc | 0.890% | 11.252% | -6.941% | 149.724% | 68.119% | -29.689% | -57.746% |
Medmira Inc. | 6.730% | -0.893% | 8.824% | -10.484% | -14.615% | - | - |
Comments
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for NVIV provided by MarketBeat